KaloBios Pharmaceuticals, Inc. Bankruptcy New Filing Alert: Order Regarding The Plan Of Reorganization

On May 6, 2016, an order regarding the plan of reorganization was filed in the bankruptcy case of KaloBios Pharmaceuticals, Inc. and its affiliates.

The filing was assigned docket number 411 and is described on the court’s official docket as follows:

Order Designating and Confirming Stalking Horse as Winning Bidder and Stalking Horse SPA as Winning Bid, in each Instance for the Primary Plan Transaction. (related document(s)[293], [379], [398]) Order Signed on 5/6/2016. (NAB)

KaloBios Pharmaceuticals, Inc. filed for bankruptcy protection, or had an involuntary bankruptcy petition filed against it, on December 29, 2015. The bankruptcy case is pending before the United States Bankruptcy Court for the District of Delaware. The case number for the lead bankruptcy case is 15-12628. The bankruptcy case is currently assigned to United States Bankruptcy Judge Laurie Selber Silverstein. The law firm of Morris, Nichols, Arsht & Tunnell LLP is acting as lead bankruptcy counsel to KaloBios Pharmaceuticals, Inc. in the bankruptcy case.


Leave a Reply